MediGene AG (MDGEF)
0.10
0.00 (0.00%)
USD |
OTCM |
Nov 12, 16:00
MediGene Market Cap : 1.474M for Nov. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 1.474M |
| November 11, 2026 | 1.474M |
| November 10, 2026 | 1.474M |
| November 09, 2026 | 1.474M |
| November 06, 2026 | 1.474M |
| November 05, 2026 | 1.474M |
| November 04, 2026 | 1.474M |
| November 03, 2026 | 1.474M |
| November 02, 2026 | 1.474M |
| October 30, 2026 | 1.474M |
| October 29, 2026 | 1.474M |
| October 28, 2026 | 1.474M |
| October 27, 2026 | 1.474M |
| October 26, 2026 | 1.474M |
| October 23, 2026 | 1.474M |
| October 22, 2026 | 1.474M |
| October 21, 2026 | 1.474M |
| October 20, 2026 | 1.474M |
| October 19, 2026 | 1.474M |
| October 16, 2026 | 1.474M |
| October 15, 2026 | 1.474M |
| October 14, 2026 | 1.474M |
| October 13, 2026 | 1.474M |
| October 12, 2026 | 1.474M |
| October 09, 2026 | 1.474M |
| Date | Value |
|---|---|
| October 08, 2026 | 1.474M |
| October 07, 2026 | 1.474M |
| October 06, 2026 | 1.474M |
| October 05, 2026 | 1.474M |
| October 02, 2026 | 1.474M |
| October 01, 2026 | 1.474M |
| September 30, 2026 | 1.474M |
| September 29, 2026 | 1.474M |
| September 28, 2026 | 1.474M |
| September 25, 2026 | 1.474M |
| September 24, 2026 | 1.474M |
| September 23, 2026 | 1.474M |
| September 22, 2026 | 1.474M |
| September 21, 2026 | 1.474M |
| September 18, 2026 | 1.474M |
| September 17, 2026 | 1.474M |
| September 16, 2026 | 1.474M |
| September 15, 2026 | 1.474M |
| September 14, 2026 | 1.474M |
| September 11, 2026 | 1.474M |
| September 10, 2026 | 1.474M |
| September 09, 2026 | 1.474M |
| September 08, 2026 | 1.474M |
| September 04, 2026 | 1.474M |
| September 03, 2026 | 1.474M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| InflaRx NV | 182.74M |
| BioNTech SE | 21.08B |
| Immatics NV | 992.78M |
| Arrowhead Pharmaceuticals, Inc. | 6.655B |
| Oncolytics Biotech, Inc. | 46.37M |
Market Cap Related Metrics
| Price | 0.10 |